David S Umbaugh

13PUBLICATIONS
17CO-AUTHORS
Molecular targetsMedical biochemistry - lipidsAutomotive combustion and fuel engineeringHaematological tumoursMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 06, 2025
Author Correction: Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.

Kuo Du, David S Umbaugh, Liuyang Wang

|Mar 29, 2025
Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.

Kuo Du, David S Umbaugh, Liuyang Wang

|Mar 04, 2025
The endothelial growth factor Angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure.

David S Umbaugh, Nga T Nguyen, Steven C Curry

|Feb 22, 2025
Mixed lineage kinase domain-like protein deficiency exacerbates early injury in a mouse model of acetaminophen hepatotoxicity.

Giselle Sanchez-Guerrero, David S Umbaugh, Sawyer H Smith

|Jul 15, 2024
Translocation of Adenosine A2B Receptor to Mitochondria Influences Cytochrome P450 2E1 Activity after Acetaminophen Overdose.

Giselle Sanchez-Guerrero, David S Umbaugh, Abhay A Ramachandran

|Jan 13, 2024
Biomarker discovery in acetaminophen hepatotoxicity: leveraging single-cell transcriptomics and mechanistic insight.

David S Umbaugh, Hartmut Jaeschke

Pageof 3

Frequent Collaborators

11 joint publications

Hartmut Jaeschke

10 joint publications

Anup Ramachandran

2 joint publications

Nga T Nguyen

2 joint publications

Olamide B Adelusi